Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohe

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancerK Eguchi, H Etou, S Miyachi, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1990
Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D)Y Sasaki, M Fukuda, M Morita, et al.
International Journal of Cancer|September 4, 1996
Hypersensitivity of NIH3T3 cells transformed by H-ras gene to DNA-topoisomerase-I inhibitorsT Ohira, K Nishio, F Kanzawa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Late toxicities and complications in three-year survivors of small cell lung cancerF Oshita, T Tamura, A Kojima, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1995
A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38Y Sasaki, H Hakusui, S Mizuno, et al.
Japanese Journal of Clinical Oncology|October 1, 1995
Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary resultsF Oshita, T Kasai, T Kurata, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|March 1, 1993
[Assay of erythropoietin in serum with short term enzyme linked immunosorbent assay method--the clinical significance, Part 1: Relation to anemia in renal failure and hematological disorders]Y Ohe, K Akasaka, Y Ohno, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1993
[Assay of erythropoietin in serum with short term enzyme linked immunosorbent assay method--the clinical significance: Part 2--:Relation to serum iron, UIBC and ferritin in renal failure and hematological disorders]Y Ohe, K Akasaka, Y Ohno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I study of CPT-11 and etoposide in patients with refractory solid tumorsA Karato, Y Sasaki, T Shinkai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Chemotherapy-induced anemia in patients with primary lung cancerH Okamoto, N Saijo, T Shinkai, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancerK Eguchi, H Etou, S Miyachi, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1990
Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D)Y Sasaki, M Fukuda, M Morita, et al.
International Journal of Cancer|September 4, 1996
Hypersensitivity of NIH3T3 cells transformed by H-ras gene to DNA-topoisomerase-I inhibitorsT Ohira, K Nishio, F Kanzawa, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Late toxicities and complications in three-year survivors of small cell lung cancerF Oshita, T Tamura, A Kojima, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1995
A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38Y Sasaki, H Hakusui, S Mizuno, et al.
Japanese Journal of Clinical Oncology|October 1, 1995
Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary resultsF Oshita, T Kasai, T Kurata, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|March 1, 1993
[Assay of erythropoietin in serum with short term enzyme linked immunosorbent assay method--the clinical significance, Part 1: Relation to anemia in renal failure and hematological disorders]Y Ohe, K Akasaka, Y Ohno, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 1993
[Assay of erythropoietin in serum with short term enzyme linked immunosorbent assay method--the clinical significance: Part 2--:Relation to serum iron, UIBC and ferritin in renal failure and hematological disorders]Y Ohe, K Akasaka, Y Ohno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Phase I study of CPT-11 and etoposide in patients with refractory solid tumorsA Karato, Y Sasaki, T Shinkai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Chemotherapy-induced anemia in patients with primary lung cancerH Okamoto, N Saijo, T Shinkai, et al.
Pageof 20